Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ireland backs waits pledge with private treatment:

This article was originally published in Clinica

Executive Summary

Ireland has begun to treat the first long-wait patients under the National Treatment Purchase Fund. The initiative, announced in November 2001, enables the public health service to acquire private sector services in priority surgery areas, with the aim of reducing the longest waiting times. The government has pledged to ensure that by the end of 2002, adult and child patients will not wait longer than 12 and six months, respectively for treatment. By 2003, these targets will be reduced to six and three months; and by 2004, no patient will wait for more than three months for treatment. The government has pledged to spend an extra E73.8m ($73.8m) in 2002 to increase diagnostics and surgery activity (see Clinica No 1014, p 10).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel